Alemtuzumab
Jump to navigation
Jump to search
| Alemtuzumab | |
|---|---|
| Term | Alemtuzumab |
| Short definition | alemtuzumab (A-lem-TOO-zoo-mab) A drug used to treat B-cell chronic lymphocytic leukemia. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
alemtuzumab - (pronounced) (A-lem-TOO-zoo-mab) A drug used to treat B-cell chronic lymphocytic leukemia. It is also being studied in the treatment of other types of cancer. Alemtuzumab attaches to a protein called CD52, which is found on some types of immune cells and cancer cells. This can help the immune system kill cancer cells. Alemtuzumab is a type of monoclonal antibody. Also called Campath
External links
- Medical encyclopedia article on Alemtuzumab
- Wikipedia's article - Alemtuzumab
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski